First Time Loading...

LumiraDx Ltd
NASDAQ:LMDX

Watchlist Manager
LumiraDx Ltd Logo
LumiraDx Ltd
NASDAQ:LMDX
Watchlist
Price: 0.016 USD Market Closed
Updated: May 19, 2024

LumiraDx Ltd
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LumiraDx Ltd
Selling, General & Administrative Peer Comparison

Comparables:
SN
LIVN
EKF
AGL
CREO

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
LumiraDx Ltd
NASDAQ:LMDX
Selling, General & Administrative
-$127.3m
CAGR 3-Years
-58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Selling, General & Administrative
-$2.6B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Selling, General & Administrative
-$523.9m
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
-16%
EKF Diagnostics Holdings PLC
LSE:EKF
Selling, General & Administrative
-£16m
CAGR 3-Years
4%
CAGR 5-Years
-3%
CAGR 10-Years
-1%
Angle PLC
LSE:AGL
Selling, General & Administrative
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Creo Medical Group PLC
LSE:CREO
Selling, General & Administrative
-£43.9m
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is LumiraDx Ltd's Selling, General & Administrative?
Selling, General & Administrative
-127.3m USD

Based on the financial report for Dec 31, 2022, LumiraDx Ltd's Selling, General & Administrative amounts to -127.3m USD.

What is LumiraDx Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 3Y
-58%

Over the last year, the Selling, General & Administrative growth was -10%. The average annual Selling, General & Administrative growth rates for LumiraDx Ltd have been -58% over the past three years .